ES2059299T3 - Direccionado de agentes terapeuticos utilizando polisacaridos. - Google Patents

Direccionado de agentes terapeuticos utilizando polisacaridos.

Info

Publication number
ES2059299T3
ES2059299T3 ES92902979T ES92902979T ES2059299T3 ES 2059299 T3 ES2059299 T3 ES 2059299T3 ES 92902979 T ES92902979 T ES 92902979T ES 92902979 T ES92902979 T ES 92902979T ES 2059299 T3 ES2059299 T3 ES 2059299T3
Authority
ES
Spain
Prior art keywords
therapeutic agent
directorate
polysaccharides
complex
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92902979T
Other languages
English (en)
Other versions
ES2059299T1 (es
Inventor
Lee Josephson
Ernest V Groman
Chu Jung
Jerome M Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Magnetics Inc
Original Assignee
Advanced Magnetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Magnetics Inc filed Critical Advanced Magnetics Inc
Publication of ES2059299T1 publication Critical patent/ES2059299T1/es
Application granted granted Critical
Publication of ES2059299T3 publication Critical patent/ES2059299T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO PARA EL OBJETIVO DE UN AGENTE TERAPEUTICO PARA UNA POBLACION ESPECIFICA DE CELULAS, EN DONDE ES FORMADO UN COMPLEJO ENTRE EL AGENTE TERAPEUTICO Y UN POLISACARIDO CAPAZ DE INTERACTUAR CON UN RECEPTOR DE LA CELULA Y EN DONDE EL COMPLEJO RESULTANTE ES INTERNADO DENTRO DE LA CELULA POR ENDOCITOSIS MEDIADA POR EL RECEPTOR (RMS). EN UNA REALIZACION DE LA INVENCION, UN COMPLEJO DE UN AGENTE TERAPEUTICO CONTENIENDO HIERRO Y ARABINOGALACTANO POLISACARIDO, PUEDE SER FORMADO Y USADO PARA SUMINISTRAR HIERRO ESPECIFICAMENTE A HEPATOCITOS POR RME.
ES92902979T 1990-12-19 1991-12-13 Direccionado de agentes terapeuticos utilizando polisacaridos. Expired - Lifetime ES2059299T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63001790A 1990-12-19 1990-12-19

Publications (2)

Publication Number Publication Date
ES2059299T1 ES2059299T1 (es) 1994-11-16
ES2059299T3 true ES2059299T3 (es) 1997-10-01

Family

ID=24525421

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92902979T Expired - Lifetime ES2059299T3 (es) 1990-12-19 1991-12-13 Direccionado de agentes terapeuticos utilizando polisacaridos.

Country Status (9)

Country Link
EP (1) EP0563249B1 (es)
JP (1) JP3357362B2 (es)
AT (1) ATE151991T1 (es)
CA (1) CA2097589C (es)
DE (2) DE563249T1 (es)
DK (1) DK0563249T3 (es)
ES (1) ES2059299T3 (es)
GR (2) GR940300001T1 (es)
WO (1) WO1992011037A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5490991A (en) * 1986-07-03 1996-02-13 Advanced Magnetics, Inc. Directed delivery of radioprotectants using a receptor specific carrier
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
GB9119762D0 (en) 1991-09-16 1991-10-30 Filler Aaron G Particulate agents for nmt
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
PT101422B (pt) * 1993-12-06 1997-06-30 Ineti Inst Biotec Q F E Tecnol Formulacoes lipossomicas contendo vidarabina e/ou derivados, com indice terapeutico elevado e processo para a sua preparacao
CZ219498A3 (cs) 1996-01-10 1998-12-16 Nycomed Imaging A/S Kontrastní prostředek
GB9600427D0 (en) * 1996-01-10 1996-03-13 Nycomed Imaging As Contrast media
US6387390B1 (en) * 1998-10-05 2002-05-14 The Penn State Research Foundation Compositions and methods for enhancing receptor-mediated cellular internalization
FR2755976B1 (fr) * 1996-11-15 1999-01-15 Idm Immuno Designed Molecules Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
US6093382A (en) 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
AU5085800A (en) * 1999-05-21 2000-12-12 Nycomed Imaging As Method of magnetic resonance imaging
GB9921579D0 (es) * 1999-09-13 1999-11-17 Nycomed Imaging As
US7082326B2 (en) 2000-03-31 2006-07-25 Amersham Health As Method of magnetic resonance imaging
CN1095472C (zh) * 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 叶酸－多聚糖复合物，其制备方法和以该复合物为活性成分的药物组合物
IT1319665B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di corticosteroidi con polimeri polisaccaridici naturali.
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
AU2005219733C1 (en) 2004-03-05 2010-12-16 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid-methotrexate conjugate
US7807675B2 (en) * 2004-04-02 2010-10-05 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid-methotrexate conjugate
JP2013053103A (ja) * 2011-09-05 2013-03-21 Ltt Bio-Pharma Co Ltd 薬物を封入した肝臓集積性ナノ粒子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857505A (en) * 1987-03-09 1989-08-15 American Cyanamid Company Sustained release compositions for parenteral administration and their use
WO1990001295A1 (en) * 1988-08-04 1990-02-22 Advanced Magnetics, Incorporated Receptor mediated endocytosis type mri contrast agents

Also Published As

Publication number Publication date
GR3023358T3 (en) 1997-08-29
GR940300001T1 (en) 1994-02-28
CA2097589A1 (en) 1992-06-20
WO1992011037A2 (en) 1992-07-09
ES2059299T1 (es) 1994-11-16
DK0563249T3 (da) 1997-11-03
DE69125848T2 (de) 1997-07-31
DE563249T1 (de) 1994-03-03
JPH06503347A (ja) 1994-04-14
ATE151991T1 (de) 1997-05-15
EP0563249B1 (en) 1997-04-23
CA2097589C (en) 1998-05-05
EP0563249A1 (en) 1993-10-06
JP3357362B2 (ja) 2002-12-16
DE69125848D1 (de) 1997-05-28
WO1992011037A3 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
ES2059299T3 (es) Direccionado de agentes terapeuticos utilizando polisacaridos.
DE3766157D1 (de) Kupplungsmittel zum radiomarkieren von proteinen.
GB2017105A (en) Method of preparing enzyme conjugates their use and coupling agents for use in the method
DK588487A (da) Forbedrede metalholdige farmaceutiske midler
WO2001005433A3 (en) Delivery and retention of activity agents to lymph nodes
DK507183D0 (da) Bifunktionelt chelateringsmiddel
DK0774005T3 (da) Overfladeudtrykkelse af enzymer i genorienteret prodrug-terapi
ES2175968T3 (es) Complejo de platino, su preparacion y aplicacion terapeutica.
DE3581768D1 (de) Tensidepraeparate.
SE9700733D0 (sv) Absorberande alster
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
JO1866B1 (en) Anti-virus agents
GB1556176A (en) Cationic fabric softening and anti static agents with an solubility in water
IL121861A (en) Prostate radiotherapy apparatus
ZA9915B (en) Use of oxidation promoting chemicals in the oxidation of oxidizable galactose type of alcohol configuration containing polymer.
ES8402153A1 (es) Un procedimiento para preparar una composicion solida comprimida para la limpieza de dentaduras postizas.
YU180791A (sh) Injekcioni proizvod za sitni pesak i druge porozne materijale
NL7904474A (nl) Werkwijze voor het verlagen van de concentratie aan eindstandige carboxylgroepen in uit een smelt gesponnen vezels.
FR2682794B1 (fr) Borne mobile delivrant de facon simultanee des messages visuels et olfactifs vers le public.
ATE269400T1 (de) Katabolisch nicht reprimierte substrat- beschränkte hefe-stämme
PL199773A1 (pl) Sposob laczenia przegubowych lacznikow z walcami i urzadzenie do stosowania tego sposobu w walcarkach pionowych
JPS52152518A (en) Preparation of heat-resistant inogranic material
IT226752Z2 (it) Cabina afonica in particolare per ribattitrici non automatiche
AU87256S (en) Door latch
ES8600925A1 (es) Procedimiento para la obtencion de una composicion para el tratamiento de cabello a base de resina carboxilica

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563249

Country of ref document: ES